Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00582_DB01268> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00582_DB01268 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00582_DB01268 label "DDI between Voriconazole and Sunitinib - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of sunitinib by decreasing its metabolism. Additive QTc prolongation may also occur. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of sunitinib if voriconazole is initiated, discontinued or dose changed. [drugbank_resource:DB00582_DB01268]" assertion.
- drugbank_resource:DB00582_DB01268 identifier "drugbank_resource:DB00582_DB01268" assertion.
- drugbank_resource:DB00582_DB01268 title "DDI between Voriconazole and Sunitinib - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of sunitinib by decreasing its metabolism. Additive QTc prolongation may also occur. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of sunitinib if voriconazole is initiated, discontinued or dose changed." assertion.